New China Life Insurance Company Ltd.:企業の戦略・SWOT・財務情報

◆英語タイトル:New China Life Insurance Company Ltd. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C1132
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

New China Life Insurance Company Ltd. – Strategy, SWOT and Corporate Finance Report
Summary

New China Life Insurance Company Ltd. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

New China Life Insurance Company Ltd. (NCI) provides a range of life insurance products and services to individuals and institutional customers. The company’s offerings include whole life insurance, universal life insurance, health insurance, accident insurance,annuity insurance and child insurance. It also offers group life insurance, group health insurance, critical illness insurance, investment-linked insurance and participating life insurance. The company, through its subsidiaries, offers equity investment, micro finance, real estate development and medical services. NCI also acts as an agent for domestic and international insurance companies, provides insurance related consulting services, and conducts capital management operations. It is headquartered in Beijing, China.

The company reported gross written premiums of RMB109.3 billion for the fiscal year ended December 2017 (FY2017) a decline of 2.9% over that in FY2016.

Scope

- Detailed information on New China Life Insurance Company Ltd. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting New China Life Insurance Company Ltd. in the form of a SWOT analysis
- An in-depth view of the business model of New China Life Insurance Company Ltd. including a breakdown and examination of key business segments
- Intelligence on New China Life Insurance Company Ltd.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about New China Life Insurance Company Ltd., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of New China Life Insurance Company Ltd. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess New China Life Insurance Company Ltd. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on New China Life Insurance Company Ltd.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
New China Life Insurance Company Ltd.: Company Overview 9
New China Life Insurance Company Ltd.: Overview and Key Facts 9
New China Life Insurance Company Ltd.: Overview 9
New China Life Insurance Company Ltd.: Key Facts 9
New China Life Insurance Company Ltd.: Key Employees 11
New China Life Insurance Company Ltd.: Key Employee Biographies 13
New China Life Insurance Company Ltd.: Major Products and Services 22
New China Life Insurance Company Ltd.: Company History 23
New China Life Insurance Company Ltd.: Management Statement 24
New China Life Insurance Company Ltd.: Locations and Subsidiaries 30
New China Life Insurance Company Ltd.: Key Competitors 31
New China Life Insurance Company Ltd.: Company Analysis 32
New China Life Insurance Company Ltd.: Business Description 32
New China Life Insurance Company Ltd.: SWOT Analysis 33
New China Life Insurance Company Ltd.: SWOT Overview 33
New China Life Insurance Company Ltd.: Strengths 33
New China Life Insurance Company Ltd.: Weaknesses 33
New China Life Insurance Company Ltd.: Opportunities 34
New China Life Insurance Company Ltd.: Threats 34
New China Life Insurance Company Ltd.: Corporate Financial Deals Activity 35
New China Life Insurance Company Ltd.: Financial Deals Overview 35
New China Life Insurance Company Ltd.: Targets and Partners 37
New China Life Insurance Company Ltd.: Top Deals 2014 – 2018YTD* 38
New China Life Insurance Company Ltd.: Mergers and Acquisitions 39
New China Life Insurance Company Ltd.: Corporate Venturing 40
New China Life Insurance Company Ltd.: Recent Developments 41
New China Life Insurance Company Ltd.: News and Events Summary 41
New China Life Insurance Company Ltd.: Corporate Governance 41
New China Life Insurance Company Ltd.: Financial Deals 42
Appendix 43
Contact Us 43
Methodology 43
About MarketLine 44

List of Tables
Table 1: New China Life Insurance Company Ltd.: Key Facts
Table 2: New China Life Insurance Company Ltd.: Key Employees
Table 3: New China Life Insurance Company Ltd.: Locations and Subsidiaries
Table 4: New China Life Insurance Company Ltd.: Key Competitors
Table 5: New China Life Insurance Company Ltd.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: New China Life Insurance Company Ltd.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: New China Life Insurance Company Ltd.: M&A Average Deal Size - Value (US$m)
Table 8: New China Life Insurance Company Ltd.: Targets and Partners
Table 9: New China Life Insurance Company Ltd.: Top Deals 2014 - 2018YTD*
Table 10: New China Life Insurance Company Ltd.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 11: New China Life Insurance Company Ltd.: M&A Activity by Geography (2014 - YTD*2018)
Table 12: New China Life Insurance Company Ltd.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 13: New China Life Insurance Company Ltd.: Corporate Venturing by Geography (2014 - YTD*2018)
Table 14: New China Life Insurance Company Ltd.: News and Events Summary
Table 15: New China Life Insurance Company Ltd.: Corporate Governance
Table 16: New China Life Insurance Company Ltd.: Financial Deals

List of Figures
Figure 1: New China Life Insurance Company Ltd.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: New China Life Insurance Company Ltd.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: New China Life Insurance Company Ltd.: M&A Average Deal Size - Value (US$m)
Figure 4: New China Life Insurance Company Ltd.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: New China Life Insurance Company Ltd.: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: New China Life Insurance Company Ltd.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 7: New China Life Insurance Company Ltd.: Corporate Venturing by Geography (2014 - YTD*2018)

★海外企業調査レポート[New China Life Insurance Company Ltd.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Supernus Pharmaceuticals Inc (SUPN):企業の財務・戦略的SWOT分析
    Supernus Pharmaceuticals Inc (SUPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • iCAD Inc (ICAD):医療機器:M&Aディール及び事業提携情報
    Summary iCAD Inc (iCAD) develops and markets computer aided detection (CAD) solutions and workflow solutions for mammography (film-based, digital radiography (DR) and computed radiography (CR), Magnetic Resonance Imaging (MRI), and Computed Tomography (CT). iCAD products find application in detectio …
  • Clarius Group Limited (CND):企業の財務・戦略的SWOT分析
    Clarius Group Limited (CND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Aero Precision Industries, Inc.:企業の戦略・SWOT・財務情報
    Aero Precision Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Aero Precision Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Danske Bank A/S:企業のM&A・事業提携・投資動向
    Danske Bank A/S - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Danske Bank A/S Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Everist Genomics Inc-医療機器分野:企業M&A・提携分析
    Summary Everist Genomics Inc (Everest Health), formerly Genetics Squared Inc is a developer of prognostics, medical diagnostic and therapeutic selection technologies. The company provides angiodefender cardiovascular disease diagnostic system, a non invasive device that is used for combining sensor …
  • Legend Mining Ltd:企業の戦略・SWOT・財務情報
    Legend Mining Ltd - Strategy, SWOT and Corporate Finance Report Summary Legend Mining Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Seres Therapeutics Inc (MCRB):企業の財務・戦略的SWOT分析
    Summary Seres Therapeutics Inc (Seres), is a microbiome therapeutics platform company that develops a novel class of biological drugs. The company creates a new class of medicines to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis. The company’ …
  • Prima Meat Packers Ltd:企業の戦略・SWOT・財務分析
    Prima Meat Packers Ltd - Strategy, SWOT and Corporate Finance Report Summary Prima Meat Packers Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Rocky Brands, Inc. (RCKY):企業の財務・戦略的SWOT分析
    Rocky Brands, Inc. (RCKY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Cinkarna Celje d.d. Celje (CICG):企業の財務・戦略的SWOT分析
    Cinkarna Celje d.d. Celje (CICG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Metropolitan Bank & Trust Company (MBT):企業の財務・戦略的SWOT分析
    Metropolitan Bank & Trust Company (MBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Novavax Inc (NVAX):製薬・医療:M&Aディール及び事業提携情報
    Summary Novavax Inc (Novavax) is a clinical-stage biotechnology company that focuses on the discovery, development and commercialization of vaccines to prevent a range of infectious diseases. Its product portfolio includes recombinant nanoparticle vaccines and adjuvants. The company develops vaccine …
  • Ramsay Health Care Limited:企業の戦略・SWOT・財務情報
    Ramsay Health Care Limited - Strategy, SWOT and Corporate Finance Report Summary Ramsay Health Care Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • PanOptica Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary PanOptica Inc (PanOptica) is a clinical-stage biopharmaceutical company that develops topical eye drops for the treatment of sight-threatening eye diseases. The company concentrates on candidates that are at or near the investigational new drug application stage. It develops PAN-90806, a nov …
  • Imperial Metals Corporation:企業の戦略・SWOT・財務情報
    Imperial Metals Corporation - Strategy, SWOT and Corporate Finance Report Summary Imperial Metals Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Tate & Lyle PLC:企業のM&A・事業提携・投資動向
    Tate & Lyle PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Tate & Lyle PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Tessco Technologies Incorporated (TESS):企業の財務・戦略的SWOT分析
    Tessco Technologies Incorporated (TESS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • KDDI Corporation:企業の戦略・SWOT・財務分析
    KDDI Corporation - Strategy, SWOT and Corporate Finance Report Summary KDDI Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • eResearchTechnology Inc:企業の戦略的SWOT分析
    eResearchTechnology Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆